Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.31 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5001377 | 0.86 | CYP19A1 (0.38) | ATAD2 | |
| SCHEMBL5505340 | 0.85 | CYP19A1 (0.37) | ATAD2 | |
| SCHEMBL4997606 | 0.83 | ATAD2 (0.44) | ATAD2 | |
| SCHEMBL5004922 | 0.79 | MEN1 (0.34) | ATAD2 | |
| SCHEMBL5004930 | 0.77 | BMPR1B (0.42) | ATAD2 | |
| SCHEMBL4992293 | 0.76 | CHRM1 (0.38) | PER2CRY2 | |
| SCHEMBL5511206 | 0.76 | BMPR1B (0.41) | ATAD2 | |
| SCHEMBL5116891 | 0.75 | ATAD2 (0.50) | ATAD2PER2CRY2 | |
| SCHEMBL4997031 | 0.74 | F10 (0.43) | — | |
| SCHEMBL4997023 | 0.74 | F10 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080262056-A1 | Oxindole Oxazolidinones as Antibacterial Agents | PFIZER INC | 2008-10-23 | — | — | US | disclosed |
| US-7435751-B2 | 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents | JOSYULA VARA PRASAD VENKATA NAGENDRA | 2008-10-14 | — | — | US | disclosed |
| US-20060229349-A1 | 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents | JOSYULA VARA PRASAD V N | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229349-A1 | 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents | OXA1L, MRPL21, FOXM1 | ATAD2 2084/4885PER2 4578/4885CRY2 4031/4885 |
| US-20080262056-A1 | Oxindole Oxazolidinones as Antibacterial Agents | OXA1L, OXSR1, OXER1 | ATAD2 1891/4885PER2 4278/4885CRY2 2957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.